Selected Start-Ups (1/07)
Executive SummaryIn Vivo briefly summarizes the technologies of these recently founded companies: Acute Innovations, Advanced Liquid Logic, Cardioxyl Pharmaceuticals, OrthoMimetics, Predictive Biosciences, and TetraPhase Pharmaceuticals.
You may also be interested in...
Through an initial public offering, Egyptian branded generics supplier Rameda intends to raise funds to buy both products and companies in the Middle East and North Africa.
ImCheck’s $53m series B financing will be used to develop antibodies that activate gamma delta T-cells for use against cancer and autoimmune diseases, its CEO tells Scrip.
Canada’s Aurinia Pharmaceuticals expects to file a US NDA in the first half of next year on the use of its next-generation calcineurin inhibitor, voclosporin, in lupus nephritis, a condition with no approved therapies.